Roth Capital analyst George Kelly lowered the firm’s price target on Xponential Fitness (XPOF) to $13 from $14 and keeps a Buy rating on the shares. One-time legal/lease expenses, elevated closures, and lagging development schedules obscured the resiliency of the company’s scaled brands, which are worth well in excess of the company’s current enterprise value, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XPOF:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue